Clarius Group LLC’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$859K Sell
2,118
-676
-24% -$274K 0.05% 165
2025
Q1
$1.39M Sell
2,794
-190
-6% -$94.5K 0.09% 104
2024
Q4
$1.55M Buy
2,984
+176
+6% +$91.6K 0.11% 87
2024
Q3
$1.73M Sell
2,808
-68
-2% -$41.8K 0.12% 81
2024
Q2
$1.59M Buy
2,876
+349
+14% +$193K 0.11% 85
2024
Q1
$1.47M Sell
2,527
-453
-15% -$263K 0.1% 90
2023
Q4
$1.58M Sell
2,980
-759
-20% -$403K 0.13% 90
2023
Q3
$1.89M Sell
3,739
-1,010
-21% -$511K 0.18% 65
2023
Q2
$2.48M Sell
4,749
-141
-3% -$73.6K 0.19% 63
2023
Q1
$2.82M Sell
4,890
-126
-3% -$72.6K 0.24% 52
2022
Q4
$2.76M Sell
5,016
-105
-2% -$57.8K 0.25% 57
2022
Q3
$2.6M Buy
5,121
+216
+4% +$110K 0.26% 52
2022
Q2
$2.67M Sell
4,905
-722
-13% -$392K 0.27% 49
2022
Q1
$3.76M Hold
5,627
0.3% 41
2021
Q4
$3.76M Sell
5,627
-388
-6% -$259K 0.3% 41
2021
Q3
$3.44M Buy
6,015
+131
+2% +$74.8K 0.31% 42
2021
Q2
$2.97M Buy
+5,884
New +$2.97M 0.27% 45
2021
Q1
Sell
-4,122
Closed -$1.92M 399
2020
Q4
$1.92M Buy
4,122
+511
+14% +$238K 0.21% 52
2020
Q3
$1.59M Sell
3,611
-352
-9% -$155K 0.2% 56
2020
Q2
$1.44M Buy
3,963
+746
+23% +$270K 0.2% 60
2020
Q1
$912K Buy
3,217
+261
+9% +$74K 0.17% 71
2019
Q4
$991K Sell
2,956
-6
-0.2% -$2.01K 0.16% 76
2019
Q3
$863K Buy
2,962
+355
+14% +$103K 0.16% 81
2019
Q2
$765K Buy
2,607
+296
+13% +$86.9K 0.15% 79
2019
Q1
$633K Buy
+2,311
New +$633K 0.15% 82